Ann Lab Med.  2023 Jan;43(1):111-113. 10.3343/alm.2023.43.1.111.

Comparison of the Clinical Performance of the Point-of-care STANDARD M10 SARS-CoV-2 and Xpert Xpress SARS-CoV-2 Assays

• Hong KH
• Lee J
• Kim SY
• Oh Y
• Cho HW
• Lee H

• KMID: 2551613
• DOI: http://doi.org/10.3343/alm.2023.43.1.111

Figure

• 

  Fig. 1 Probit analysis of the LoD of the STANDARD M10 SARS-CoV-2 assay using (A) clinical samples and (B) the AccuPlex SARS-CoV-2 Molecular Controls Kit - Full Genome (SeraCare, Milford, MA, USA). Abbreviations: Ct, cycle threshold; LoD, limit of detection; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Reference

1. Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, et al. 2020; Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 8:1192–200. DOI: 10.1016/S2213-2600(20)30454-9.

2. Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C, et al. 2021; Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 3:CD013705. DOI: 10.1002/14651858.CD013705. PMID: 32845525. PMCID: PMC8078202.

3. Hong KH, Kim GJ, Roh KH, Sung H, Lee J, Kim SY, et al. 2022; Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea. Ann Lab Med. 42:391–7. DOI: 10.3343/alm.2022.42.4.391. PMID: 35177559. PMCID: PMC8859556.

4. Lee J, Kim SY, Huh HJ, Kim N, Sung H, Lee H, et al. 2021; Clinical performance of the Standard Q COVID-19 Rapid Antigen Test and simulation of its real-world application in Korea. Ann Lab Med. 41:588–92. DOI: 10.3343/alm.2021.41.6.588. PMID: 34108286. PMCID: PMC8203442.

5. Kim SY, Lee J, Sung H, Lee H, Han MG, Yoo CK, et al. 2020; Pooling upper respiratory specimens for rapid mass screening of COVID-19 by real-time RT-PCR. Emerg Infect Dis. 26:2469–72. DOI: 10.3201/eid2610.201955. PMID: 32844739. PMCID: PMC7510748.